Tags

Morningstar Sustainalytics

Samsung Biologics Secures Top ESG Rating From Morningstar Sustainalytics

Samsung Biologics Secures Top ESG Rating From Morningstar Sustainalytics

November 05, 2026 | 15:23
Biopharmaceutical manufacturer Samsung Biologics earned a Negligible Risk classification in the latest Morningstar Sustainalytics environmental, social, and governance risk evaluation.

Latest News

Saudi Tourism Minister Inaugurates Saudi Land Pavilion in London

Saudi Tourism Minister Inaugurates Saudi Land Pavilion in London

Samsung Biologics Secures Top ESG Rating From Morningstar Sustainalytics

Samsung Biologics Secures Top ESG Rating From Morningstar Sustainalytics

Zuellig Pharma Acquires Hangzhou Facility to Expand Chinese Clinical Sourcing

Zuellig Pharma Acquires Hangzhou Facility to Expand Chinese Clinical Sourcing

Antigua Receives 20 Zeekr Electric Vehicles for Commonwealth Summit

Antigua Receives 20 Zeekr Electric Vehicles for Commonwealth Summit

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia Ansarada
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society CSR Swing for the Kids
World News
virs-publications-vir
timeout-vn
ptbv2020